Kenyans daily expectations of the unlocking of the five marked counties seem to be deteriorating each and every day after the daily updates on Covid-19 situation in the country.
In today's updates, 456 individuals are alleged to have tested positive for the novel virus in a sample size of 4,134 in the last 24 hours, with the positivity rate declining to 11.8 percent.
18 patients have succumbed to the complications of Covid-19, while 490 others have fully recovered from the deadly infection.
However, the worrying news that has been put across by the Ministry of Health is that of the scarcity of a unique Covid-19 drug that was effective in improving chances of survival and reduce the need for mechanical ventilation in Covid-19 patients.
The drug which has been identified as Tocilizumab was developed by a Swiss pharmaceutical company known as Roche goes at 200K shillings per dose, is out of stock in some facilities while top pharmacies don't want to restock because of its high cost.
Kenyans are encouraged to continue following the strict measures of containing the virus as this is the only way we can successfully manage the deadly virus.
Stay home, stay safe and together we will be winners!
Content created and supplied by: TheDailyScoop.com (via Opera News )
Opera News is a free to use platform and the views and opinions expressed herein are solely those of the author and do not represent, reflect or express the views of Opera News. Any/all written content and images displayed are provided by the blogger/author, appear herein as submitted by the blogger/author and are unedited by Opera News. Opera News does not consent to nor does it condone the posting of any content that violates the rights (including the copyrights) of any third party, nor content that may malign, inter alia, any religion, ethnic group, organization, gender, company, or individual. Opera News furthermore does not condone the use of our platform for the purposes encouraging/endorsing hate speech, violation of human rights and/or utterances of a defamatory nature. If the content contained herein violates any of your rights, including those of copyright, and/or violates any the above mentioned factors, you are requested to immediately notify us using via the following email address operanews-external(at)opera.com and/or report the article using the available reporting functionality built into our Platform See More